Immuno-Oncology and Technology: Volume 5 to Volume 8

Title: Immuno-Oncology and Technology: Fostering Advances in Cancer Research and Treatment

Introduction: Immuno-Oncology and Technology (IOTECH), the latest addition to the European Society for Medical Oncology’s portfolio of top-tier journals, is committed to publishing high-quality original research articles, reviews, perspectives, technology-focused papers, letters to the editor, and editorials. By providing a platform for today’s leaders in the field of Immuno-Oncology, IOTECH aims to promote progress and innovation in this crucial area of cancer research.

Leadership and Scope: Under the leadership of Editor in Chief, Professor John Haanen, and an international team of expert editors and editorial board members, IOTECH publishes quarterly issues focused on pre-clinical and clinical studies. The journal’s scope encompasses natural and therapy-induced innate and adaptive immune responses against solid and hematological cancers.

Emphasizing Technological Developments: In addition to its core focus on immuno-oncology, IOTECH places a strong emphasis on technological developments within the field. The journal seeks to highlight advances in technology that help decipher and improve clinical outcomes, showcasing the intersection of technological innovation and cancer treatment.

A Sister Journal to Prestigious Publications: As a sister journal to the renowned Annals of Oncology and ESMO Open, IOTECH is part of a family of prestigious publications that continue to contribute significantly to oncology research and practice. This connection allows IOTECH to leverage a strong foundation of rigorous scientific exploration and a commitment to advancing the field of oncology.

Conclusion: Through its commitment to disseminating high-quality research and its focus on the nexus of immuno-oncology and technology, Immuno-Oncology and Technology is making significant strides in the field of cancer research and treatment. By fostering a global community of researchers, clinicians, and thought leaders, IOTECH is playing a crucial role in shaping the future of oncology.

Volume 5: Pages 1-22 (March 2020)

Volume 6: Pages 1-18 (June 2020)

Volume 7: Pages 1-22 (September 2020)

Volume 8: Pages 1-20 (December 2020)